Authors' reply: Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients

S-H Fu^{1

2

3}, C-Y Wang^{4

5

6}, C-Y Li²

Affiliations

¹ Department of Orthopedics, National Taiwan University Hospital Yunlin Branch, Douliu, Taiwan.
² Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
³ Department of Orthopedics, National Taiwan University Hospital, Taipei, Taiwan.
⁴ School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
⁵ College of Medicine, Graduate Institute of Clinical Pharmacy, National Taiwan University, Taipei, Taiwan.
⁶ Department of Pharmacy, National Taiwan University Hospital Yunlin Branch, Douliu, Taiwan.

Free article

Comment

S-H Fu et al. J Intern Med. 2022 Mar.

Free article

. 2022 Mar;291(3):386-387.

doi: 10.1111/joim.13401. Epub 2021 Nov 14.

S-H Fu^{1

2

3}, C-Y Wang^{4

5

6}, C-Y Li²

¹ Department of Orthopedics, National Taiwan University Hospital Yunlin Branch, Douliu, Taiwan.
² Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
³ Department of Orthopedics, National Taiwan University Hospital, Taipei, Taiwan.
⁴ School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
⁵ College of Medicine, Graduate Institute of Clinical Pharmacy, National Taiwan University, Taipei, Taiwan.
⁶ Department of Pharmacy, National Taiwan University Hospital Yunlin Branch, Douliu, Taiwan.

No abstract available

Comment on

Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study.
Fu SH, Wang CY, Hung CC, Lee CC, Yang RS, Huang CC, Farn CJ, Lin WH, Chen HM, Hsiao FY, Lin JW, Li CY. Fu SH, et al. J Intern Med. 2021 Dec;290(6):1194-1205. doi: 10.1111/joim.13354. Epub 2021 Aug 2. J Intern Med. 2021. PMID: 34237171
Regarding: Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients.
Wu YC, Chen S, Wu PL, Tsou HK, Wei JC. Wu YC, et al. J Intern Med. 2022 Mar;291(3):384-385. doi: 10.1111/joim.13400. Epub 2021 Nov 14. J Intern Med. 2022. PMID: 34779048 No abstract available.

1. Wu Y.-C., Chen S., Wu P.-L., Tsou H.-K., Wei J. C.-C. Regarding: Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients. J Intern Med. 2022;291(3):384-5.
1. Wang CY, Fu SH, Huang CC, Hung CC, Yang RS, Hsiao FY. Visualisation of the unmet treatment need of osteoporotic fracture in Taiwan: a nationwide cohort study. Int J Clin Pract. 2018;72(10):e13246.
1. Lewiecki EM. Risk communication and shared decision making in the care of patients with osteoporosis. J Clin Densitom. 2010;13(4):335-45.
1. Hsing AW, Ioannidis JP. Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175(9):1527-9.
1. Fu SH, Wang CY, Hung CC, Lee CC, Yang RS, Huang CC, et al. Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: a population-based cohort study. J Intern Med. 2021;290(6):1194-1205.